These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 8414320

  • 1. Second-look laparotomy in carcinoma of the fallopian tube.
    Barakat RR, Rubin SC, Saigo PE, Lewis JL, Jones WB, Curtin JP.
    Obstet Gynecol; 1993 Nov; 82(5):748-51. PubMed ID: 8414320
    [Abstract] [Full Text] [Related]

  • 2. Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study.
    Gadducci A, Landoni F, Sartori E, Maggino T, Zola P, Gabriele A, Rossi R, Cosio S, Fanucchi A, Tisi G.
    Gynecol Oncol; 2001 May; 81(2):150-9. PubMed ID: 11330942
    [Abstract] [Full Text] [Related]

  • 3. Paclitaxel-based chemotherapy in carcinoma of the fallopian tube.
    Gemignani ML, Hensley ML, Cohen R, Venkatraman E, Saigo PE, Barakat RR.
    Gynecol Oncol; 2001 Jan; 80(1):16-20. PubMed ID: 11136563
    [Abstract] [Full Text] [Related]

  • 4. Second-look laparotomy in stage III epithelial ovarian cancer: clinical variables associated with disease status.
    Berek JS, Hacker NF, Lagasse LD, Poth T, Resnick B, Nieberg RK.
    Obstet Gynecol; 1984 Aug; 64(2):207-12. PubMed ID: 6539884
    [Abstract] [Full Text] [Related]

  • 5. Second-look laparotomy for ovarian cancer provides reliable prognostic information and improves survival.
    Friedman RL, Eisenkop SM, Wang HJ.
    Gynecol Oncol; 1997 Oct; 67(1):88-94. PubMed ID: 9345362
    [Abstract] [Full Text] [Related]

  • 6. Second-look laparotomy in stage I ovarian cancer following comprehensive surgical staging.
    Rubin SC, Jones WB, Curtin JP, Barakat RR, Hakes TB, Hoskins WJ.
    Obstet Gynecol; 1993 Jul; 82(1):139-42. PubMed ID: 8515914
    [Abstract] [Full Text] [Related]

  • 7. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response.
    Vaccarello L, Rubin SC, Vlamis V, Wong G, Jones WB, Lewis JL, Hoskins WJ.
    Gynecol Oncol; 1995 Apr; 57(1):61-5. PubMed ID: 7705701
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of fallopian tube carcinoma with cisplatin, doxorubicin, and cyclophosphamide.
    Morris M, Gershenson DM, Burke TW, Kavanagh JJ, Silva EG, Wharton JT.
    Obstet Gynecol; 1990 Dec; 76(6):1020-4. PubMed ID: 2234710
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Impact of second look laparotomy and secondary cytoreductive surgery at second-look laparotomy in ovarian cancer patients.
    Obermair A, Sevelda P.
    Acta Obstet Gynecol Scand; 2001 May; 80(5):432-6. PubMed ID: 11328220
    [Abstract] [Full Text] [Related]

  • 12. Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy.
    Petit T, Velten M, d'Hombres A, Marchal C, Montbarbon X, Mornex F, Quetin P, Gérard JP, Romestaing P, Carrie C.
    Gynecol Oncol; 2007 Jan; 104(1):104-8. PubMed ID: 16987544
    [Abstract] [Full Text] [Related]

  • 13. Second-look laparotomy in the management of fallopian tube carcinoma.
    Cormio G, Gabriele A, Maneo A, Marzola M, Lissoni A, Mangioni C.
    Acta Obstet Gynecol Scand; 1997 Apr; 76(4):369-72. PubMed ID: 9174434
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Second-look laparotomy after modified posterior exenteration: patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer.
    Spirtos NM, Eisenkop SM, Schlaerth JB, Ballon SC.
    Am J Obstet Gynecol; 2000 Jun; 182(6):1321-7. PubMed ID: 10871445
    [Abstract] [Full Text] [Related]

  • 17. Correlation of platelet count with second-look laparotomy results and disease progression in patients with advanced epithelial ovarian cancer.
    Bozkurt N, Yuce K, Basaran M, Kose F, Ayhan A.
    Obstet Gynecol; 2004 Jan; 103(1):82-5. PubMed ID: 14704249
    [Abstract] [Full Text] [Related]

  • 18. Secondary cytoreductive surgery at second-look laparotomy in advanced ovarian cancer: a Gynecologic Oncology Group Study.
    Williams L, Brunetto VL, Yordan E, DiSaia PJ, Creasman WT.
    Gynecol Oncol; 1997 Aug; 66(2):171-8. PubMed ID: 9264559
    [Abstract] [Full Text] [Related]

  • 19. CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy.
    Juretzka MM, Barakat RR, Chi DS, Iasonos A, Dupont J, Abu-Rustum NR, Poynor EA, Aghajanian C, Spriggs D, Hensley ML, Sabbatini P.
    Gynecol Oncol; 2007 Jan; 104(1):176-80. PubMed ID: 16996584
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the role of second-look surgery in ovarian cancer.
    Chambers SK, Chambers JT, Kohorn EI, Lawrence R, Schwartz PE.
    Obstet Gynecol; 1988 Sep; 72(3 Pt 1):404-8. PubMed ID: 3405557
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.